Endogenous bystander killing mechanisms enhance the activity of novel FAP-specific CAR-T cells against glioblastoma.

MLA

Yu, Wenbo, et al. “Endogenous Bystander Killing Mechanisms Enhance the Activity of Novel FAP-Specific CAR-T Cells against Glioblastoma.” Clinical & Translational Immunology, vol. 13, no. 7, July 2024, p. e1519. EBSCOhost, https://doi.org/10.1002/cti2.1519.

APA

Yu, W., Truong, N. T., Polara, R., Gargett, T., Tea, M. N., Pitson, S. M., Cockshell, M. P., Bonder, C. S., Ebert, L. M., & Brown, M. P. (2024). Endogenous bystander killing mechanisms enhance the activity of novel FAP-specific CAR-T cells against glioblastoma. Clinical & Translational Immunology, 13(7), e1519. https://doi.org/10.1002/cti2.1519

Chicago

Yu, Wenbo, Nga Th Truong, Ruhi Polara, Tessa Gargett, Melinda N Tea, Stuart M Pitson, Michaelia P Cockshell, Claudine S Bonder, Lisa M Ebert, and Michael P Brown. 2024. “Endogenous Bystander Killing Mechanisms Enhance the Activity of Novel FAP-Specific CAR-T Cells against Glioblastoma.” Clinical & Translational Immunology 13 (7): e1519. doi:10.1002/cti2.1519.